Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$15.39 - $20.25 $30,780 - $40,500
2,000 Added 17.54%
13,400 $259,000
Q4 2021

Feb 15, 2022

SELL
$15.91 - $18.72 $74,777 - $87,984
-4,700 Reduced 29.19%
11,400 $197,000
Q3 2021

Nov 16, 2021

SELL
$13.06 - $17.24 $28,732 - $37,928
-2,200 Reduced 12.02%
16,100 $269,000
Q1 2021

May 18, 2021

BUY
$11.06 - $12.87 $202,398 - $235,521
18,300 New
18,300 $219,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.